Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACE Hemoglobin A1c (HbA1c) Reagent

K-Number: K170623 · 2018-02-27

Decision Date2018-02-27
Product CodeLCP
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

ACE Hemoglobin A1c (HbA1c) Reagent is a medical device manufactured by Alfa Wassermann Diagnostic Technologies, LLC. It received FDA 510(k) clearance on 2018-02-27 under approval number K170623. The device is classified under product code LCP. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACE Hemoglobin A1c (HbA1c) Reagent?

ACE Hemoglobin A1c (HbA1c) Reagent is a medical device that received FDA 510(k) clearance on 2018-02-27. It is manufactured by Alfa Wassermann Diagnostic Technologies, LLC. The 510(k) number is K170623.

When was ACE Hemoglobin A1c (HbA1c) Reagent approved by the FDA?

ACE Hemoglobin A1c (HbA1c) Reagent received FDA 510(k) clearance on 2018-02-27, under approval number K170623.

What company makes ACE Hemoglobin A1c (HbA1c) Reagent?

ACE Hemoglobin A1c (HbA1c) Reagent is manufactured by Alfa Wassermann Diagnostic Technologies, LLC.

What is the FDA product code for ACE Hemoglobin A1c (HbA1c) Reagent?

The FDA product code for ACE Hemoglobin A1c (HbA1c) Reagent is LCP.

Related Clinical Trials

Related Devices (Code: LCP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.